Opinion: On “The Impact Factor Fallacy”

Papers published in low-impact journals are not necessarily low-quality scientific contributions.

Written byFrieder Michel Paulus, Sören Krach, and Nicole Cruz
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

© BRYAN SATALINO

Eugene Garfield’s pioneering work on the journal impact factor (IF) fundamentally changed how institutions evaluate scientific quality. What was initially sought to help make decisions about journal subscriptions today influences academia far beyond the stocking of libraries. Scientists may receive grants, bonuses, and tenure depending on the perceived impact of the journals in which they publish their research. This practice has been widely criticized because the IF is a poor indicator for the number of citations of a specific journal article, and motivating scientists based on citation rates and journal IFs might have unwanted side effects, potentially jeopardizing the reliability and credibility of science.

Using IFs for such purposes also results in reasoning and argumentation fallacies. Policies that rely on journal-based metrics for evaluating scientific ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies